Skip to main content

Month: April 2023

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference from April 25 to 26, 2023. Event: 2023 Bloom Burton & Co. Healthcare Investor ConferenceDate: April 25-26, 2023Location: Toronto, Ontario Medexus Presentation: Tuesday, April 25 at 9:30 AM Eastern time Ken d’Entremont, Medexus’s Chief Executive Officer, and Marcel Konrad, Medexus’s Chief Financial Officer, will deliver a presentation on April 25, 2023 at 9:30 AM Eastern time and will be available for in-person one-on-one meetings throughout the conference. A live and recorded webcast of the Medexus presentation will be available on the Investors—News & Events section of Medexus’s corporate...

Continue reading

SmartCentres Declares Distribution for April 2023

TORONTO, April 18, 2023 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of April 2023 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on May 15, 2023 to unitholders of record on April 28, 2023. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 185 strategically located properties in communities across the country. SmartCentres has approximately $11.7 billion in assets and owns 34.8 million square feet of income producing value-oriented retail and first-class office space with 98.0% occupancy, on 3,500 acres of owned land...

Continue reading

National Research Corporation to Broadcast its 2023 First Quarter Conference Call Live on the Internet

Lincoln, Nebraska, April 18, 2023 (GLOBE NEWSWIRE) — National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 first quarter earnings conference call on Wednesday, May 3, 2023. The Company’s results for the 2023 first quarter will be released after the close of the market on Tuesday, May 2, 2023. The live broadcast of National Research Corporation’s conference call will begin at 11:00 a.m. Eastern Time on May 3, 2023. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast.  A live audio webcast can be accessed at https://events.q4inc.com/attendee/253347934. The webcast will also be available for replay. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations...

Continue reading

Eddy Smart Home Solutions Ltd. Announces Late Filing of 2022 Year End Financial Statements

TORONTO, April 18, 2023 (GLOBE NEWSWIRE) — Eddy Smart Home Solutions Ltd. (“Eddy” or the “Company”) (TSXV: EDY), announces that it will be late in filing its financial statements for the year ended December 31, 2022. It anticipates being able to file its 2022-year end financials, together with the related management’s discussion and analysis, and CEO and CFO certificates (the “Annual Documents”) on May 5, 2023, after the close. Completion of the Company’s audit has taken longer than anticipated as a result of a number of transactions and other factors in 2022 including its public listing, growth in contracted revenues and an acquisition. Notwithstanding the anticipated delay, the Company continues to operate normally without disruption and is working diligently and expeditiously with its auditors to...

Continue reading

BeyondSpring Provides Business Update and Reports Year End 2022 Financial Results

– SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration – BeyondSpring Completed Enrollment of Three Investigator-Initiated Trials (IIT) with Plinabulin in the U.S. for Multiple Cancer Indications NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on using its novel technology platform for drug discovery and development of innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today provided a business update and reported results for the year ended December 31, 2022. “I am pleased to report that BeyondSpring’s subsidiary, SEED Therapeutics, has made significant headway in advancing internal and external collaboration assets...

Continue reading

SP Plus Corporation to Release First Quarter 2023 Results on May 3, 2023

CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) — SP Plus Corporation (NASDAQ: SP) today announced that it expects to release first quarter 2023 earnings on Wednesday, May 3, 2023, after the close of market. Later that same day, the Company will host a conference call at 4:00 PM (Central Time) that can be accessed via webcast at http://ir.spplus.com.   To listen to the live call, individuals are directed to the investor relations section of the company’s website, www.spplus.com, at least fifteen minutes early to register, download and install any necessary audio software. For those who cannot listen to the live broadcast, replays will be available shortly after the call on the website and accessible for 30 days. About SP+ SP+ blends industry-leading technology and best-in-class operations to deliver mobility solutions that enable the...

Continue reading

Appian To Announce First Quarter 2023 Financial Results on May 9

MCLEAN, Va., April 18, 2023 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced that it will release financial results for the first quarter ended March 31, 2023, following the close of market on Tuesday, May 9, 2023. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 4:30 p.m. Eastern Time. To access the call, please use this Registration Link. Once registered, participants can dial in the same way they always have, using their phone with a dial in and PIN, or they can choose the Call Me option for instant dial to their phone. The conference call will also be available live via webcast on the Investor Relations page of the Company’s website at http://investors.appian.com. A webcast replay of the conference...

Continue reading

ADT To Release First Quarter 2023 Results On Tuesday, May 2, 2023

BOCA RATON, Fla., April 18, 2023 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) will release its first quarter 2023 financial results before the market opens on Tuesday, May 2, 2023. Following the release, management will host a conference call at 10:00 a.m. ET to discuss the financial results and lead a question-and-answer session. Participants may listen to a live webcast through the investor relations website at investor.adt.com. A replay of the webcast will be available on the website within 24 hours of the live event. Alternatively, participants may listen to the live call by dialing 1-888-660-6144 (domestic) or 1-929-203-0865 (international), and requesting the ADT First Quarter 2023 Earnings Conference Call. An audio replay will be available for two weeks following the call, and can be accessed by dialing 1-800-770-2030 (domestic)...

Continue reading

Amerant Bank Names Caroline Vérot Moore Houston Market President

Caroline Vérot Moore EVP, Houston Market PresidentHouston, April 18, 2023 (GLOBE NEWSWIRE) — Amerant Bank, one of the nation’s largest community banks, with a growing presence in Houston, Texas, has appointed Caroline Vérot Moore as EVP, Houston Market President. Vérot Moore will oversee multiple business sectors in the market, including commercial banking, commercial real estate, retail, private and business banking, specialty finance, and treasury management. With over 20 years of experience in corporate banking, Vérot Moore is a highly skilled finance professional specializing in business development, credit analysis and portfolio management. “We are pleased to welcome Caroline to Amerant. Her extensive experience in corporate banking and knowledge of the Houston market makes her the ideal leader for our team in this key...

Continue reading

Minerals Technologies Further Expands in China and India Paper Markets

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today announced that it has entered into three long-term precipitated calcium carbonate (PCC) supply agreements that will further expand the Company’s Specialty Additives product line in China and India. The agreements are with three major paper companies – Andhra Paper Limited located in Rajahmundry, India; Nine Dragons Paper located in Beihai, China; and Zhejiang Zhefeng New Materials Company located in Quzhou, China – to build and operate on-site precipitated calcium carbonate (PCC) satellite plants. The combined volume equals more than 180,000 metric tons per year of PCC, and the sites are expected to be in operation in late 2023 and early 2024. “MTI continues to drive growth in China and India as our newest technologies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.